saigonbao.com
Pharmaceutical Industry
Trump signs healthcare executive order that includes a win for pharma companies - Reuters
US begins probes into pharmaceutical and chip imports, setting stage for tariffs - CNN
Pharma tariffs could be a generics problem - Axios
Trump pharma tariff threat raises specter of shortages, price hikes - The Hill
Novartis plans $23B expansion of manufacturing in US, including North Jersey site - Bergen Record
Donald Trump pledges to cut drug prices for Americans - Financial Times
U.S. puts drug tariffs on the table, threatening entire supply chains - The Globe and Mail
Trump Initiates Chips and Drug Probes Ahead of More Tariffs - Bloomberg
Drugs Licensed
Judge issues suspended sentence on drug, license charges - The Legacy Newspaper
The Chinese CEO Who Believes Her Cancer Drug Can Beat Merck’s Bestseller - WSJ - WSJ
Proposed legislation paves the way for AI to prescribe drugs - MobiHealthNews
Head of New RFK Jr. Vaccine Study Practiced Unlicensed Medicine on Autistic Kids - The 74
Synthetic Approaches to the New Drugs Approved during 2023 - ACS Publications
Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica
Anesthesiologist on probation for drug use could have license pulled after failing to do mandatory testing - 10News.com
FDA has approved drug treatments and authorized others - fda.gov
Another Ohio beauty spa loses license over bootleg drug allegations - Ohio Capital Journal
Drugs Patents
EPO and UPC disagree on validity of Amgen’s patent for cholesterol drug - JUVE Patent
Reduce drug spending by drastically simplifying monopolies on drugs - statnews.com
8 key drug patents expiring soon — and what it means for the market - Quartz
These are the drugs that lose their U.S. patents in 2025: most are in common use across the country by million - Diario AS
How drug patents pave the way to profit - MSN
Senate Judiciary Committee to Consider Bills Targeting Pharma Patents and Pricing - IPWatchdog.com
Sponsored Content: The Connection Between Patents and High Drug Prices - Politico
Novo Nordisk, Bayer, GSK among giants accused in drug delivery suits - Life Sciences Intellectual Property Review
USPTO Confirms Unreliable Patent Numbers by I-MAK in Drug Pricing Debate - Hudson Institute
Drugs Generics
Pharma tariffs could be a generics problem - Axios
3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes - Yahoo Finance
Americans depend on foreign-made generic drugs too much. Tariffs can fix that. - MarketWatch
Tariffs threaten generic drug production and supply - Fmr. FDA commissioner (XPH:NYSEARCA) - Seeking Alpha
Trump Tariffs Could Raise Generic Drug Prices, Worsen Shortages - Pharmacy Practice News
All generic drugs are not equal, study finds - The Ohio State University
How the IRA is impacting the generic drug market - PhRMA
AG Yost Secures $49.1 Million Settlement In Price-Fixing Cases Involving Generic Drugs - Ohio Attorney General (.gov)
Attorney General Bonta Urges Consumers to Check Eligibility for Compensation for Inflated Generic Drug Prices - State of California - Department of Justice (.gov)
FDA Food and Drug Administration
US FDA to phase out animal testing in drug development - Reuters
F.D.A. Layoffs Could Raise Drug Costs and Erode Food Safety - The New York Times
Constituent Update - fda.gov
FDA tobacco official is removed from post in latest blow to health agency’s leadership - AP News
FDA planning for fewer food and drug inspections due to layoffs, officials say - CBS News
HHS Secretary Kennedy Directs FDA to Explore Rulemaking to Eliminate Pathway for Companies to Self-Affirm Food Ingredients Are Safe - HHS.gov
RFK Jr. brings FDA under tighter control with HHS workforce cuts - statnews.com
Get Assistance from the FDA Human Foods Program (HFP) - fda.gov
Use of the "Healthy" Claim on Food Labeling - fda.gov
Pharmaceutical Companies
Trump signs healthcare executive order that includes a win for pharma companies - Reuters
Pharma bosses face down investor angst on tariffs, HHS chaos - BioPharma Dive
Trump pharma tariff threat raises specter of shortages, price hikes - The Hill
Pharma tariffs could be a generics problem - Axios
U.S. puts drug tariffs on the table, threatening entire supply chains - The Globe and Mail
Johnson & Johnson warns pharma tariffs could cause drug shortages - Financial Times
Pharma tariffs could leave little room to hide with sweeping probe underway - Endpoints News
J&J’s Earnings Beat as Pharma Girds for Looming US Tariffs - Bloomberg
Trump admin moves toward semiconductor, pharmaceutical tariffs - Fox Business
Retail Pharmacies
MetroHealth Opens New Pharmacy at Brooklyn Health Center - Newsroom MetroHealth
Attorneys general want Congress to prohibit PBMs from owning affiliated pharmacies - statnews.com
Navigating Retail and Specialty Lite Success: How Your Pharmacy Strategy Impacts Brand Performance - Fierce Pharma
Nearly 1 in 3 retail pharmacies have closed since 2010 - UC Berkeley School of Public Health
Committee advances PBM bill keeping CVS, others from having retail pharmacies - Talk Business & Politics
Proposed ban on drug middlemen owning retail pharmacies passes Arkansas House committee - Arkansas Advocate
Canada launches antitrust probe into Cigna's Express Scripts unit - Reuters
Alabama House passes bill that would limit CBD to minor-restricted stores, pharmacies - Alabama Political Reporter
Canada Probes Express Scripts Over Alleged Anti-Competitive Conduct - PYMNTS.com
Drug Marketing
GSK (GSK) Faces Regulatory Scrutiny Over Drug Marketing Practices - GuruFocus
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - Reuters
Few psych drugs from past decade are on HCPs' radars: survey - Fierce Pharma
AstraZeneca India surrenders marketing approval of prostate cancer drug - Business Standard
China Issues New Domestic Responsible Person Rules for Foreign Drug Marketing Authorization Holders - Morgan Lewis
A shadowy market for weight-loss drugs has emerged online - Science News
AG: 11 people charged in connection with open-air drug market - WBAL-TV
Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica
Opinion | Why Hasn't RFK Jr. Paused Drug Ads? - MedPage Today